Mouse 2',3'-cyclic nucleotide 3'-phosphodiesterase (Cnp) gene promoter

5' regulatory region of the mouse Cnp gene (2',3'-cyclic nucleotide 3'-phosphodiesterase) that directs expression to oligodendrocytes in the CNS and Schwann cells in the PNS, tracking the developmental onset of endogenous Cnp expression during myelination (Gravel et al. 1998; Yuan et al. 2002). Standard promoter for targeting reporters to the oligodendrocyte lineage.

Length: 3046 bp

Strength: moderate

Tissue: Oligodendrocytes in the CNS and Schwann cells in the PNS; the originally characterized 4 kb fragment also shows off-target activity in peripheral nerve, testis, and thymus (Gravel et al. 1998; Yuan et al. 2002)

Expression: constitutive

Origin: Mouse (Mus musculus) Cnp gene, 5' flanking region

Characteristics

A 4 kb 5' fragment of the mouse Cnp gene drives lacZ expression that is restricted to oligodendrocytes in the CNS, increases with age, and concentrates in adult white matter, but the same fragment also activates in peripheral nerve, testis, and thymus, showing it is not exclusively oligodendroglial (Gravel et al. 1998). A Cnp promoter-EGFP transgene instead restricts fluorescence to the oligodendrocyte and Schwann cell lineages specifically, enabling live visualization and FACS purification of these cells at defined developmental stages, with the proliferation rate of EGFP-positive progenitors decreasing with age (Yuan et al. 2002).

Applications: Used to drive fluorescent reporters such as EGFP in the oligodendrocyte and Schwann cell lineages of mouse for live imaging, FACS purification of oligodendroglial cells at defined developmental stages, and electrophysiological characterization of progenitors versus mature oligodendrocytes (Yuan et al. 2002); also used to overexpress CNP itself to study its role in oligodendrocyte membrane and myelin structure (Gravel et al. 1996).

Limitations: The originally characterized 4 kb fragment is not oligodendrocyte-exclusive — it also drives expression in peripheral nerve, testis, and thymus, so off-target activity should be checked outside CNS assays (Gravel et al. 1998). Overexpressing CNP itself under this promoter produces aberrant oligodendrocyte membranes and inhibits myelin compaction, so it is dose-sensitive for cargo overexpression (Gravel et al. 1996).

Sequence

You must be signed in to view the full sequence.